Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionCapital Advisors, Ltd. LLC
Latest Disclosed Ownership3,016 shares
Latest Disclosed Value $ 1,061
Capital Advisors, Ltd. LLC reports 16.32% decrease in ownership of AMGN / Amgen Inc.

On April 16, 2026 - Capital Advisors, Ltd. LLC filed a 13F-HR form disclosing ownership of 3,016 shares of Amgen Inc. (CH:AMGN) valued at $1,061 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 3,604 shares of Amgen Inc.. This represents a change in shares of -16.32% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F AMGEN COM 031162100 3,016 -588 -16.32 1 0.00 0.1206
2026-01-21 2025-12-31 13F AMGEN COM 031162100 3,604 -78 -2.12 1 0.00 0.1331
2025-10-16 2025-09-30 13F AMGEN COM 031162100 3,682 1,492 68.13 1 0.1173
2025-07-24 2025-06-30 13F AMGEN COM 031162100 2,190 -90 -3.95 1 0.0754
2025-04-15 2025-03-31 13F AMGEN COM 031162100 2,280 144 6.74 1 0.0935
2025-02-04 2024-12-31 13F AMGEN COM 031162100 2,136 -44 -2.02 1 0.0702
2024-10-24 2024-09-30 13F AMGEN COM 031162100 2,180 5 0.23 1 0.0871
2024-07-25 2024-06-30 13F AMGEN COM 031162100 2,175 77 3.67 1 0.0883
2024-04-18 2024-03-31 13F AMGEN COM 031162100 2,098 18 0.87 1 0.0778
2024-02-02 2023-12-31 13F AMGEN COM 031162100 2,080 3 0.14 1 0.0841
2023-10-27 2023-09-30 13F AMGEN COM 031162100 2,077 55 2.72 1 0.0855
2023-07-26 2023-06-30 13F AMGEN COM 031162100 2,022 225 12.52 0 0.0671
2023-05-03 2023-03-31 13F AMGEN COM 031162100 1,797 -163 -8.32 0 0.0713
2023-02-07 2022-12-31 13F AMGEN COM 031162100 1,960 -544 -21.73 0 -100.00 0.0783
2022-11-09 2022-09-30 13F AMGEN COM 031162100 2,504 -15 -0.60 564 -7.99 0.1098
2022-08-05 2022-06-30 13F AMGEN COM 031162100 2,519 19 0.76 613 1.32 0.1148
2022-05-09 2022-03-31 13F AMGEN COM 031162100 2,500 5 0.20 605 7.84 0.1006
2022-02-08 2021-12-31 13F AMGEN COM 031162100 2,495 -175 -6.55 561 -1.23 0.0905
2021-11-12 2021-09-30 13F AMGEN COM 031162100 2,670 313 13.28 568 -1.22 0.1014
2021-08-10 2021-06-30 13F AMGEN COM 031162100 2,357 804 51.77 575 48.96 0.1032
2021-05-13 2021-03-31 13F AMGEN COM 031162100 1,553 5 0.32 386 8.43 0.0708
2021-02-10 2020-12-31 13F AMGEN COM 031162100 1,548 4 0.26 356 -9.18 0.0786
2020-11-03 2020-09-30 13F AMGEN COM 031162100 1,544 4 0.26 392 7.99 0.0978
2020-08-06 2020-06-30 13F AMGEN COM 031162100 1,540 -463 -23.12 363 -10.59 0.0958
2020-05-08 2020-03-31 13F AMGEN COM 031162100 2,003 8 0.40 406 -15.59 0.1273
2020-02-03 2019-12-31 13F AMGEN COM 031162100 1,995 6 0.30 481 24.94 0.1226
2019-10-23 2019-09-30 13F AMGEN COM 031162100 1,989 8 0.40 385 5.48 0.1066
2019-07-31 2019-06-30 13F AMGEN COM 031162100 1,981 91 4.81 365 1.67 0.1031
2019-05-01 2019-03-31 13F AMGEN COM 031162100 1,890 0 0.00 359 -2.45 0.0971
2019-01-29 2018-12-31 13F AMGEN COM 031162100 1,890 7 0.37 368 -5.64 0.1086
2018-10-24 2018-09-30 13F AMGEN COM 031162100 1,883 753 66.64 390 86.60 0.1101
2018-07-20 2018-06-30 13F AMGEN COM 031162100 1,130 8 0.71 209 9.42 0.0653
2018-04-23 2018-03-31 13F AMGEN COM 031162100 1,122 7 0.63 191 -1.55 0.0618
2018-01-16 2017-12-31 13F AMGEN COM 031162100 1,115 6 0.54 194 -6.28 0.0640
2017-10-25 2017-09-30 13F AMGEN COM 031162100 1,109 6 0.54 207 8.95 0.0726
2017-07-26 2017-06-30 13F AMGEN COM 031162100 1,103 7 0.64 190 5.56 0.0699
2017-04-19 2017-03-31 13F AMGEN COM 031162100 1,096 -29 -2.58 180 9.76 0.0693
2017-01-20 2016-12-31 13F AMGEN COM 031162100 1,125 42 3.88 164 -9.39 0.0677
2016-10-14 2016-09-30 13F AMGEN COM 031162100 1,083 5 0.46 181 10.37 0.0796
2016-07-13 2016-06-30 13F AMGEN COM 031162100 1,078 6 0.56 164 1.86 0.0771
2016-04-15 2016-03-31 13F AMGEN COM 031162100 1,072 7 0.66 161 -6.94 0.0801
2016-01-25 2015-12-31 13F AMGEN COM 031162100 1,065 4 0.38 173 17.69 0.0902
2015-10-20 2015-09-30 13F AMGEN COM 031162100 1,061 5 0.47 147 -9.26 0.0811
2015-07-14 2015-06-30 13F AMGEN COM 031162100 1,056 5 0.48 162 -3.57 0.0839
2015-04-22 2015-03-31 13F AMGEN COM 031162100 1,051 1,051 0.00 168 0.0871
2015-01-29 2014-12-31 13F AMGEN COM 031162100 0 -1,043 -100.00 0 -100.00
2014-10-29 2014-09-30 13F AMGEN COM 031162100 1,043 4 0.38 146 18.70 0.0831
2014-07-25 2014-06-30 13F/A-1 AMGEN COM 031162100 1,039 4 0.39 123 -3.91 0.0690
2014-07-23 2014-06-30 13F AMGEN COM 031162100 1,039 4 1,230 68,974.1027
2014-04-09 2014-03-31 13F AMGEN COM 031162100 1,035 5 0.49 128 8.47 0.0752
2014-01-24 2013-12-31 13F AMGEN COM 031162100 1,030 1,030 118 0.0784
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.